Shopping Cart
- Remove All
- Your shopping cart is currently empty
Z-LEVD-FMK is a cell-permeable caspase-4 inhibitor with potential anticancer activity, capable of eliminating LPS-induced GCLC protein degradation and inducing apoptosis in cancer cells.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $204 | In Stock | |
5 mg | $594 | In Stock | |
10 mg | $891 | In Stock | |
25 mg | $1,520 | In Stock | |
50 mg | $1,980 | In Stock | |
1 mL x 10 mM (in DMSO) | $928 | In Stock |
Description | Z-LEVD-FMK is a cell-permeable caspase-4 inhibitor with potential anticancer activity, capable of eliminating LPS-induced GCLC protein degradation and inducing apoptosis in cancer cells. |
In vitro | Z-LEVD-FMK is a specific inhibitor of caspase-4. Z-LEVD-FMK (2 μM) completely eliminated IL-8 protein production in induced hRPE cells. [1] Z-LEVD-FMK was most active in blocking 17β-estradiol (E2) -induced apoptosis. In addition, z-LEVD-fmk completely blocked the cutting of ADP-ribose polymerase (PARP), and E2 inhibited growth and apoptotic morphology. [2] Z-LEVD-FMK (50 μM) treated for 72 hours only inhibited IL-17A-induced caspase-4 cleavage and N-terminal GSDMD up-regulation in CRC cells. There was no significant effect on the expression of NLRP3 inflammasome (NLRP3, ASC, caspase-1). [3] |
Molecular Weight | 652.71 |
Formula | C31H45FN4O10 |
Cas No. | 1135688-25-3 |
Smiles | [C@@H](NC([C@@H](NC(OCC1=CC=CC=C1)=O)CC(C)C)=O)(C(N[C@H](C(N[C@@H](CC(OC)=O)C(CF)=O)=O)C(C)C)=O)CCC(OC)=O |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 100 mg/mL (153.21 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.